New possibilities of prevention of infection in the newborn

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 2, 2011, Pages 29-31

  Borghesi, Alessandro ^a   Tzialla, Chryssoula ^a   Decembrino, Lidia ^a   Manzoni, Paolo ^b   Stronati, Mauro ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

Antibiotics; Immunoglobulins; Lactoferrin; Mannose binding lectin; MBL; Neonatal infection; Newborn; Nosocomial; Prevention; Sepsis

Indexed keywords

ALTASTAPH; AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; FLUCONAZOLE; GENTAMICIN; HEPARIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; INH A21; LACTOBACILLUS RHAMNOSUS EXTRACT; LACTOFERRIN; MANNOSE BINDING LECTIN; NYSTATIN; PAGIBAXIMAB; PENICILLIN G; PLACEBO; PROBIOTIC AGENT; PROCALCITONIN; SERUM AMYLOID A; TEFIMAZUMAB; UNCLASSIFIED DRUG; VERONATE; ANTIFUNGAL AGENT; STAPHYLOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIBODY TITER; CATHETER INFECTION; CLINICAL PRACTICE; COAGULASE NEGATIVE STAPHYLOCOCCUS; EXTREMELY LOW BIRTH WEIGHT; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; MYCOSIS; NECROTIZING ENTEROCOLITIS; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS INFECTION; SYSTEMIC MYCOSIS; TREATMENT DURATION; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; IMMUNOTHERAPY; INFECTION CONTROL; METHODOLOGY; NEWBORN; NEWBORN DISEASE; ORGANIZATION AND MANAGEMENT; STATISTICS; UTILIZATION REVIEW;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CROSS INFECTION; HEPARIN; HUMANS; IMMUNOTHERAPY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; LACTOFERRIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES;

EID: 80053550263     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.604934     Document Type: Review

References (17)

1. Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet 2005;365:891-900.
2. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK Jr. Nosocomial infection in the NICU: a medical complication or unavoidable problem? J Perinatol 2004;24:382-388. (Pubitemid 38931094)
3. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, Stolfi I, et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421-1428.
4. Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, Salem S, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics 2007;119:e284-e291. (Pubitemid 46397835)
5. Birch P, Ogden S, Hewson M. A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F252-F257.
6. Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M; iCAP Group (Improving Antibiotic Prescribing in Primary Care). Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011;96:F4-F8.
7. Stocker M, Hop WC, van Rossum AM. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal earlyonset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study. BMC Pediatr. 2010;10:89.
8. Ng PC, Ang IL, Chiu RW, Lam HS, Wong RP, et al. Hostresponse biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010. Aug 2;120(8):2989-3000.
9. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-1666. (Pubitemid 33126821)
10. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, Tridapalli E, et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007;356:2483-2495. (Pubitemid 46919774)
11. Howell A, Isaacs D, Halliday R; Australasian Study Group For Neonatal Infections. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed 2009;94:F429-F433.
12. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, Erdeve O, Dilmen U. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2011;96:F164-F168.
13. Shah PS, Kaufman DA. Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants. Cochrane Database Syst Rev. 2009;(2):CD006449.
14. de Benedetti F, Auriti C, DUrbano LE, Ronchetti MP, Rav L, Tozzi A, Ugazio AG, Orzalesi MM. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res 2007;61: 325-328.
15. Frakking FN, Brouwer N, van Eijkelenburg NK, Merkus MP, Kuijpers TW, Offringa M, Dolman KM. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol 2007;150:255-262. (Pubitemid 47609559)
16. Dzwonek AB, Neth OW, Thiébaut R, Gulczynska E, Chilton M, Hellwig T, Bajaj-Elliott M, et al. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr Res 2008;63:680-685.
17. Schlapbach LJ, Mattmann M, Thiel S, Boillat C, Otth M, Nelle M, Wagner B, et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010;51:153-162.